TY - JOUR
T1 - microRNAs in gliomas
T2 - small regulators of a big problem.
AU - Silber, Joachim
AU - James, C. David
AU - Hodgson, J. Graeme
PY - 2009
Y1 - 2009
N2 - Gliomas are the most common form of primary brain tumors and are associated with a poor clinical outcome. The molecular mechanisms that contribute to gliomagenesis have become increasingly clear in recent years, yet much remains to be learned. This is particularly true for the role of microRNAs in gliomagenesis, as an appreciation for the significance of aberrant miRNA expression in human cancer has only emerged in the last 5 years. It is now evident that microRNAs regulate a wide variety of tumorigenic processes including cellular proliferation, differentiation, angiogenesis, invasion, and apoptosis. Here we review the current state of knowledge related to the role of microRNAs in glial tumor development. This is a rapidly evolving field and it is likely that we have only begun to appreciate the involvement of microRNAs in relation to glioma formation, and the therapeutic potential of microRNAs to improve outcome for glioma patients.
AB - Gliomas are the most common form of primary brain tumors and are associated with a poor clinical outcome. The molecular mechanisms that contribute to gliomagenesis have become increasingly clear in recent years, yet much remains to be learned. This is particularly true for the role of microRNAs in gliomagenesis, as an appreciation for the significance of aberrant miRNA expression in human cancer has only emerged in the last 5 years. It is now evident that microRNAs regulate a wide variety of tumorigenic processes including cellular proliferation, differentiation, angiogenesis, invasion, and apoptosis. Here we review the current state of knowledge related to the role of microRNAs in glial tumor development. This is a rapidly evolving field and it is likely that we have only begun to appreciate the involvement of microRNAs in relation to glioma formation, and the therapeutic potential of microRNAs to improve outcome for glioma patients.
UR - http://www.scopus.com/inward/record.url?scp=77953623899&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=77953623899&partnerID=8YFLogxK
U2 - 10.1007/s12017-009-8087-9
DO - 10.1007/s12017-009-8087-9
M3 - Review article
C2 - 19731102
AN - SCOPUS:77953623899
SN - 1535-1084
VL - 11
SP - 208
EP - 222
JO - Neuromolecular medicine
JF - Neuromolecular medicine
IS - 3
ER -